PA
MLAB icon

Procyon Advisors’s Mesa Laboratories MLAB Stock Holding History

Procyon Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-19
Closed -$4K – 708
2020
Q2 		$4K Hold
19
– – ﹤0.01% 829
2020
Q1 		$4K Sell
19
-15
-44% -$3.7K ﹤0.01% 768
2019
Q4 		$8K Buy
+34
New +$7.96K ﹤0.01% 709

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Procyon Advisors's MLAB Position: Q3 2020 in Review

Procyon Advisors sold out of Mesa Laboratories (MLAB) in Q3 2020, closing a stake of 19 shares — an estimated $4K sold.

Procyon Advisors first reported a position in MLAB in Q4 2019 and held it in 3 quarters. The position peaked at $8K in Q4 2019. 153 funds tracked by Wall St. Rank hold MLAB as of Q3 2020.

  • Procyon Advisors reported no remaining Mesa Laboratories position as of Q3 2020 after selling out during the quarter.
  • Procyon Advisors sold 19 Mesa Laboratories shares in Q3 2020, an estimated $4K.
  • Procyon Advisors first reported a position in Mesa Laboratories in Q4 2019 and held it in 3 quarters.
  • Procyon Advisors's Mesa Laboratories position peaked at $8K in Q4 2019.
  • 153 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2020.

Based on Procyon Advisors's 13F filing for Q3 2020, filed 22 Oct 2020.